Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.033%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Oil prices close to 13-month highs, supported by Texas cold snap

Tue, 16th Feb 2021 11:32

* Texas cold snap shuts down oil wells and refineries

* Middle East supply worries raised by Yemen conflict

* Norwegian oil terminal wage dispute resolved
(Updates prices, adds UBS price forecast)

By Shadia Nasralla

LONDON, Feb 16 (Reuters) - Oil prices hovered near 13-month
highs on Tuesday, supported by a U.S. cold snap that shut wells
in the oil-producing state of Texas, though gains were capped by
a Norwegian wage deal that averted supply disruptions in Europe.

The global rollout of coronavirus vaccinations, fuelling
expectations of a recovery in the global economy and oil demand,
has also kept prices buoyant.

Keenly watched U.S. oil inventory data from the API industry
association and Energy Information Administration (EIA) will be
released this week on Wednesday and Thursday respectively, each
delayed by a day after U.S. markets were closed for a public
holiday on Monday.

Benchmark Brent crude slipped 37 cents, or 0.5%, to
$62.93 a barrel by 1434 GMT but remained 13-month peak reached
in the previous session.

U.S. West Texas Intermediate (WTI) crude futures
gained 45 cents, or 0.8%, to $59.92 after touching their highest
since early January last year.

Swiss bank UBS increased its Brent price forecast, saying it
expects the benchmark to reach $68 a barrel in the second half
of the year and $70 by March 2022, with WTI trading at a $3
discount.

Cold weather in the United States halted operations at Texas
oil wells and refineries on Monday and forced restrictions on
natural gas and crude pipeline operators.

Texas produces about 4.6 million barrels per day of oil and
is home to 31 refineries, the most of any U.S. state and
including some of the country's largest, EIA data shows.

Middle East supply concerns also rose after the Saudi-led
coalition fighting the Houthi group in Yemen said on Monday that
it had destroyed an explosive-laden drone fired by the Houthis
at the kingdom, the world's biggest oil exporter.

But in a move that helped to cap prices, Norway's oil
industry employers struck a wage deal with the Safe labour union
on Tuesday, preventing a strike at the Mongstad crude terminal,
which could have forced major offshore oil and gas fields to
shut.

(Additional reporting by Jessica Jaganathan in Singapore
Editing by Edmund Blair and David Goodman
)

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.